Investment Rating - The report suggests an "Overweight" rating for the industry, indicating a positive outlook for the next six months [48]. Core Insights - The report emphasizes the importance of domestic computing power and electricity infrastructure in the context of AI trading [1]. - It highlights two main lines for industry allocation in 2026: technology and security, and reform and growth, focusing on self-reliance and innovation in technology [42]. - The report identifies key sectors to watch, including AI capabilities, resource security, and energy safety, as well as consumer demand in non-durable goods and services [42]. Market Review - The average daily trading volume for the entire A-share market reached 2.44 trillion, an increase of over 300 billion compared to the previous week [8]. - Small-cap stocks outperformed large-cap stocks, with a balanced performance between value and growth styles [11][13]. Market Style Performance - The report notes that small-cap value stocks had a weekly increase of 4.44%, while the overall A-share index saw a rise of 1.98% [11]. - Growth stocks showed a relative disadvantage compared to value stocks, with performance fluctuating in negative territory [16] [19]. Sector Performance - The report provides insights into the performance of various sectors, indicating strong movements in certain industries while others lagged behind [28][31]. - It highlights the importance of monitoring the basic materials and energy sectors, particularly in relation to new energy developments [42]. Upcoming Industry Events - Key upcoming events include the World Mobile Communications Conference and the Apple Spring Product Launch, which may impact market sentiment and sector performance [41].

Investment Rating - The report maintains an "Overweight" rating for the pharmaceutical and biotechnology industry [1] Core Insights - The upcoming adjustment of the National Essential Medicines List (NEML) is expected to benefit traditional Chinese medicine (TCM) stocks, with a focus on companies like Zhaoli Pharmaceutical, Fangsheng Pharmaceutical, and Panlong Pharmaceutical [2][17][22] - The report ranks sub-industries in the following order of preference: innovative drugs > research services > CXO > TCM > medical devices > pharmacies [2][11] - Historical data indicates that products included in the NEML tend to experience significant sales growth, as seen with Zhaoli Pharmaceutical's Wuling Capsule, which saw sales growth rates increase from -12.82% in 2017 to 32.52% in 2021 after being included in the NEML [19][25] Summary by Sections Investment Highlights - The report suggests focusing on TCM stocks due to the imminent NEML adjustments, recommending Zhaoli Pharmaceutical, Fangsheng Pharmaceutical, and Panlong Pharmaceutical [2][17] - The report emphasizes the importance of the NEML adjustments, which have not occurred in eight years, and the potential for TCM products to gain market share [22] R&D Progress and Company Dynamics - Recent approvals and submissions include Sanofi's Dupilumab for new indications, GSK's hepatitis B therapy submission in Japan, and significant clinical trial results from various companies [5] - The report highlights the progress of innovative drugs and improved drug development pipelines across several companies, indicating a robust R&D environment [23] Market Performance - The A-share pharmaceutical index has shown a year-to-date increase of 3.0%, with notable performances from specific stocks such as Aidi Te (+36.9%) and Wanze Shares (+27.5%) [10] - The report notes that the medical device sector has outperformed other sub-sectors, with a 2.2% increase, while chemical pharmaceuticals and medical services have seen declines [10]

Investment Rating - The industry investment rating is "Overweight," indicating an expected outperformance of the industry index relative to the benchmark by more than 5% over the next six months [59]. Core Insights - The automotive parts sector has shown a weekly increase of 1.73%, ranking first among the SW automotive indices, with a year-to-date increase of 6.76% [3][18]. - The robotics sector experienced a slight increase of 0.08% this week, with a year-to-date increase of 2.63%, but underperformed compared to the automotive parts sector [3][30]. - Key developments include a strategic partnership between Zhiyuan Robotics and Minshi Group to accelerate the localization and deployment of robotics technology in Europe [3][41]. Summary by Sections Automotive Parts Sector Weekly Review - The automotive parts sector ranked first in the SW automotive index this week, with a year-to-date performance of +6.76% [3][18]. - The sector's PE (TTM) is at 88.37% historical percentile, and PB (LF) is at 81.92% historical percentile as of February 27, 2026 [3][28]. Robotics Sector Weekly Review - The robotics index increased by 0.08% this week, with a year-to-date performance of +2.63% [3][30]. - The latest PE (TTM) for the robotics sector is at 49.89% historical percentile, and PB (LF) is at 57.01% historical percentile as of February 27, 2026 [40]. Key Stock Tracking - Notable weekly gainers include Xingyuan Zhuomei (+10.64%), Bertley (+7.15%), and Feilong Co. (+7.11%) [3][48]. - Core stocks in the automotive parts sector include Fuyao Glass, Xingyu Co., Minshi Group, and Junsheng Electronics, with specific recommendations based on EPS and PE dimensions [54]. Investment Recommendations - For the automotive parts sector, focus on structural opportunities by selecting product-oriented companies and those entering high-value segments to enhance ASP [54]. - In the robotics sector, look for certainty in opportunities, particularly with the anticipated release of Optimus V3 and the application of domestic manufacturers like Xiaopeng and Yushu [54].

Investment Rating - The industry investment rating is "Overweight," indicating an expected outperformance of the industry index relative to the benchmark by more than 5% over the next six months [59]. Core Insights - The automotive parts sector has shown a weekly increase of 1.73%, ranking first among the SW automotive indices, with a year-to-date increase of 6.76% [3][18]. - The robotics sector experienced a slight increase of 0.08% this week, with a year-to-date increase of 2.63%, but underperformed compared to the automotive parts sector [3][30]. - Key developments include a strategic partnership between Zhiyuan and Minshi Group to accelerate the localization and deployment of robotic technology in Europe, and the launch of a new quadruped robot by Yushu [3][41]. Automotive Parts Sector Summary - The SW automotive parts PE (TTM) is at the historical 88.37% percentile, while the PB (LF) is at 81.92% [3][28]. - The top five gainers in the automotive parts sector this week were: Xingyuan Zhuomei (+10.64%), Berteli (+7.15%), Feilong Co. (+7.11%), Changhua Group (+5.19%), and Yinlun Co. (+4.73%) [3][48]. - The sector's trading volume has shown a slight recovery post the Lunar New Year, but demand remains affected by market conditions [3][25]. Robotics Sector Summary - The latest trading day for the robotics sector shows a PE (TTM) at 1.36 times that of the broader market, with a PB (LF) at 1.84 times [40]. - The sector's trading activity has seen a modest increase due to performances at the Spring Festival Gala, although it remains at historical lows [37][30]. - Significant events include the entry of Zhiyuan into the German market and the unveiling of a humanoid robot by Honor at an upcoming exhibition [41][43]. Investment Recommendations - For the automotive parts sector, focus on structural opportunities by selecting product-oriented companies and those entering high-value segments to enhance ASP, particularly in Europe, North America, and Southeast Asia [3][54]. - In the robotics sector, look for certainty in opportunities, especially with the anticipated release of Optimus V3 and the application developments from companies like Xiaopeng, Yushu, and Zhiyuan [3][54].

Investment Rating - The report maintains an "Overweight" rating for the non-bank financial sector [1] Core Insights - The insurance sector is expected to improve fundamentally and see valuation increases despite short-term adjustments [1] - The report highlights the rapid growth of total assets in the insurance industry and a significant increase in equity allocation [24][25] - The multi-financial sector is entering a stable transition period as the era of policy dividends has passed [32] Industry Performance - In the recent four trading days (February 24-27, 2026), only the multi-financial sector outperformed the CSI 300 index, rising by 3.18%, while the insurance sector fell by 3.76% and the overall non-bank financial sector declined by 1.30% [9][10] - Year-to-date, the multi-financial sector has increased by 4.28%, while the insurance sector has decreased by 5.71% [10] Securities Sector - Trading volume has decreased month-on-month, with February's average daily trading volume at 26,889 billion yuan, a 22.61% decline from January [15] - The average price-to-book (PB) ratio for the securities industry is projected at 1.2x for 2026 [22] Insurance Sector - By the end of 2025, the total assets of insurance companies reached 41.3 trillion yuan, a 15.1% increase from the beginning of the year [24] - The insurance sector's average solvency ratio was 181.1% at the end of 2025, indicating strong financial health [24] Multi-Financial Sector - The trust industry saw its asset scale reach 32.43 trillion yuan by mid-2025, a 20.11% year-on-year increase [32] - The futures market experienced a significant increase in trading volume and value, with January 2026 figures showing a 105.14% year-on-year growth in transaction value [36] Industry Ranking and Recommendations - The report ranks the insurance sector highest, followed by securities and other multi-financial sectors, recommending companies such as China Life, Ping An, and CITIC Securities [47]

Investment Rating - The report maintains an "Overweight" rating for the pharmaceutical and biotechnology sector [1] Core Insights - The upcoming adjustment of the National Essential Medicines List (NEML) is expected to benefit traditional Chinese medicine (TCM) stocks, with a focus on companies like Zhaoli Pharmaceutical, Fangsheng Pharmaceutical, and Panlong Pharmaceutical [2][17][22] - The report ranks sub-sectors in the following order of preference: innovative drugs > research services > CXO > TCM > medical devices > pharmacies [2][11] - Historical data indicates that products included in the NEML tend to experience significant sales growth, as seen with Zhaoli Pharmaceutical's Wuling Capsule, which saw sales growth rates increase from -12.82% in 2017 to 32.52% in 2021 after being included in the NEML [19][22] Summary by Sections Investment Highlights - The report suggests focusing on TCM stocks due to the imminent NEML adjustments, recommending Zhaoli Pharmaceutical, Fangsheng Pharmaceutical, and Panlong Pharmaceutical [2][17] - The report emphasizes the importance of the NEML adjustments, which have not occurred in eight years, and the potential for TCM products to gain market share [22] R&D Progress and Company Dynamics - Recent approvals and submissions include Sanofi's Dupilumab for new indications and GSK's hepatitis B therapy application in Japan [5] - The report highlights various companies across different therapeutic areas, including innovative drugs, ADCs, and small nucleic acids, suggesting a diversified investment approach [13][22] Market Performance - The A-share pharmaceutical index has shown a year-to-date increase of 3.0%, with notable performances from specific stocks such as Aidi Te (+36.9%) and Wanze Shares (+27.5%) [10] - The report notes that the medical sector has seen varied performance, with biopharmaceuticals and medical devices showing positive trends, while chemical pharmaceuticals and medical services have faced declines [10]

1. Report Industry Investment Rating No information about the industry investment rating is provided in the content. 2. Core Viewpoints - This week, the weekly average prices of Brent/WTI crude oil futures were $71.3/$65.9 per barrel, up $1.3/$1.1 per barrel from last week [2]. - The total US crude oil inventory, commercial crude oil inventory, strategic crude oil inventory, and Cushing crude oil inventory were 8.5/4.4/4.2/0.2 billion barrels, with a week - on - week increase of 15.99/15.99/0/0.88 million barrels respectively [2]. - US crude oil production was 13.7 million barrels per day, a week - on - week decrease of 30,000 barrels per day. The number of active US crude oil rigs this week was 407, a week - on - week decrease of 2. The number of active US fracturing fleets this week was 160, a week - on - week increase of 7 [2]. - US refinery crude oil processing volume was 15.66 million barrels per day, a week - on - week decrease of 420,000 barrels per day; the US refinery crude oil utilization rate was 88.6%, a week - on - week decrease of 2.4 percentage points [2]. - US crude oil imports, exports, and net imports were 6.66/4.31/2.35 million barrels per day, with a week - on - week change of +140,000/ - 280,000/+410,000 barrels per day respectively [2]. - The weekly average prices of US gasoline, diesel, and jet fuel were $84/$112/$89 per barrel, with a week - on - week change of +$2.7/+$8.6/ - $5.1 per barrel respectively; the price spreads with crude oil were $13/$41/$17 per barrel, with a week - on - week change of +$1.0/+$6.9/ - $6.9 per barrel respectively [2]. - US gasoline, diesel, and aviation kerosene inventories were 2.5/1.2/0.4 billion barrels, with a week - on - week change of - 1.01/+0.25/ - 1.44 million barrels respectively [2]. - US gasoline, diesel, and aviation kerosene production were 9.22/4.75/1.67 million barrels per day, a week - on - week decrease of 220,000/140,000/120,000 barrels per day respectively [2]. - US gasoline, diesel, and aviation kerosene consumption were 8.73/3.90/1.72 million barrels per day, with a week - on - week change of - 20,000/ - 860,000/+130,000 barrels per day respectively [2]. - Recommended companies include CNOOC Limited (600938.SH/0883.HK), PetroChina Company Limited (601857.SH/0857.HK), Sinopec (600028.SH/0386.HK), CNOOC Oilfield Services Limited (601808.SH), Offshore Oil Engineering Co., Ltd. (600583.SH), and CNOOC Energy Technology & Services Limited (600968.SH). Companies to be noted include Sinopec Oilfield Service Corporation (600871.SH/1033.HK), China Petroleum Engineering & Construction Corporation (600339.SH), and Sinopec Mechanical & Electrical Equipment Co., Ltd. (000852.SZ) [3]. 3. Summary by Directory 2. This Week's Performance of the Petroleum and Petrochemical Sector 2.1 Performance of the Petroleum and Petrochemical Sector No specific performance data is provided in the content. 2.2 Performance of Listed Companies in the Sector - The table shows the latest prices, total market values, and price changes in the past week, month, three months, and year of multiple listed companies in the petroleum and petrochemical sector, such as CNOOC Limited, PetroChina Company Limited, and Sinopec [22]. - The valuation table presents the stock prices, total market values, net profits attributable to the parent company, PE, and PB of multiple listed companies from 2024 to 2027 [24]. 3. Crude Oil Sector Data Tracking 3.1 Crude Oil Prices - Analyzes the price relationships and spreads between various crude oils, such as Brent, WTI, Russian Urals, and ESPO crude oils, as well as the relationships between the US dollar index, LME copper price, and WTI crude oil price [29][34][38]. 3.2 Crude Oil Inventory - Discusses the correlation between US commercial crude oil inventory and oil prices from 2010 to February 2026, and shows the data of US total crude oil inventory, commercial crude oil inventory, strategic crude oil inventory, and Cushing crude oil inventory [40][45][52]. 3.3 Crude Oil Supply - Shows the US crude oil production, the number of crude oil rigs, and the number of fracturing fleets [58][60][61]. 3.4 Crude Oil Demand - Presents the US refinery crude oil processing volume, refinery utilization rate, and the seasonal utilization rates of Shandong and Chinese major refineries [66][68][71]. 3.5 Crude Oil Import and Export - Displays the US crude oil imports, exports, and net imports, as well as the imports, exports, and net imports of crude oil and petroleum products [75][77]. 4. Refined Oil Sector Data Tracking 4.1 Refined Oil Prices - When the international crude oil price is above $80 per barrel, the increase in domestic gasoline and diesel prices slows down, and enterprises bear the profit reduction caused by cost changes. When the international crude oil price is at $80 per barrel, the spreads between domestic gasoline/diesel and crude oil reach their phased highs [82]. - Analyzes the relationships between international crude oil prices and domestic gasoline, diesel, and aviation kerosene prices and spreads from 2017 to February 2026 [85][87][102]. 4.2 Refined Oil Inventory - Shows the inventory data of US gasoline, diesel, aviation kerosene, and Singapore gasoline and diesel [120][125][135]. 4.3 Refined Oil Supply - Presents the production data of US gasoline, diesel, and aviation kerosene [137][139]. 4.4 Refined Oil Demand - Displays the consumption data of US gasoline, diesel, and aviation kerosene, as well as the number of US airport passenger security checks [143][144][152]. 4.5 Refined Oil Import and Export - Shows the import, export, and net export data of US gasoline, diesel, and aviation kerosene [154][159][160]. 5. Oilfield Services Sector Data Tracking - Analyzes the average daily rates of self - elevating and semi - submersible drilling platforms in the industry [170][174].

Investment Rating - The report maintains a "Buy" rating for the company [1]. Core Insights - The company is positioned to benefit from the dual drivers of emerging market opportunities and capacity release, particularly in high-end bearing supply [3]. - The company has a strong competitive edge through its focus on R&D, solid customer relationships, and strategic positioning in high-growth sectors such as aerospace, robotics, and new energy vehicles [3]. - The forecasted net profit for 2025-2027 is projected to be 1.53 billion, 1.96 billion, and 2.73 billion respectively, with corresponding dynamic P/E ratios of 29.59, 23.21, and 16.64 [3]. Summary by Sections 1. Company Overview - The company is a leading supplier in the needle bearing industry, with a history of over 60 years and a strong focus on R&D and high-end product development [13][14]. - It has established a solid customer base, including partnerships with global automotive suppliers, enhancing its market competitiveness [27][50]. 2. Industry Analysis - The bearing industry is experiencing a concentration trend, with increasing demand from emerging sectors such as new energy vehicles and industrial robotics [41][46]. - The market for needle bearings is expected to grow significantly, driven by the demand for high-performance components in various applications [41][54]. 3. Competitive Advantages - The company has a robust R&D framework, with a high percentage of R&D personnel and significant investment in technology, allowing it to break foreign monopolies in high-end markets [3][57]. - Its customer resources are well-established, with deep ties to top-tier global clients, which helps mitigate risks associated with market fluctuations [27][50]. - The company is strategically positioned in high-growth sectors, which are expected to provide substantial revenue growth opportunities in the coming years [3][41]. 4. Financial Projections - Revenue is projected to grow from 636.37 million in 2023 to 1,045 million by 2027, with a compound annual growth rate of approximately 12.96% [1]. - The net profit is expected to increase significantly, reflecting the company's effective cost management and operational efficiency [26][31].

Investment Rating - The industry investment rating is maintained at "Accumulate" [1] Core Insights - The port coal price remains strong, with a current spot price of 751 RMB/ton, reflecting a week-on-week increase of 29 RMB/ton [1] - Supply side shows an increase in daily average inflow to 1.749 million tons, up by 26.28% week-on-week, while daily average outflow increased to 1.6735 million tons, up by 16.03% [1][29] - The inventory at the four ports in the Bohai Rim increased to 23.968 million tons, a rise of 1.80% week-on-week [1][33] - The report anticipates that coal prices will maintain a fluctuating trend due to weak demand from downstream industrial power plants and high temperatures affecting residential demand [1] Summary by Sections 1. Market Review - The Shanghai Composite Index closed at 4,162.88 points, up 1.98% week-on-week, while the coal sector index rose by 5.92% [10] - The trading volume for the coal sector was 72.994 billion RMB, a decrease of 0.79% from the previous week [10] 2. Price Trends - Port coal prices increased, with the Qinhuangdao port price for 5500 kcal coal rising to 751 RMB/ton [16] - The price for Dazhong South Suburb 5500 kcal coal increased by 37 RMB/ton to 644 RMB/ton, while the price for Yanzhou 6000 kcal coal decreased by 10 RMB/ton to 950 RMB/ton [16][21] 3. Supply and Demand Dynamics - Daily average inflow to the Bohai Rim ports increased to 1.749 million tons, while daily average outflow rose to 1.6735 million tons [29] - The number of anchored vessels in the Bohai Rim ports increased to 116, reflecting a 7.64% week-on-week rise [33] 4. Shipping Costs - Domestic shipping costs rose by 11% week-on-week, averaging 29.78 RMB/ton [35] 5. Recommendations - The report suggests focusing on resource stocks, particularly recommending Haohua Energy and Guanghui Energy as elastic targets due to their low valuations [2][38]

Investment Rating - The report maintains a "Buy" rating for the company [1]. Core Insights - The company is positioned to benefit from the dual drivers of emerging market opportunities and capacity release, particularly in high-end bearing supply [3]. - The company has a strong competitive edge through its focus on R&D, solid customer relationships, and strategic positioning in high-growth sectors such as aerospace, robotics, and new energy vehicles [3]. - The forecasted net profit for the company is expected to grow significantly from 1.53 billion in 2025 to 2.73 billion in 2027, with corresponding dynamic P/E ratios decreasing from 29.59 to 16.64 [3]. Summary by Sections 1. Company Overview - The company is a leading supplier in the needle bearing industry, with a history of over 60 years and a strong focus on R&D and high-end product development [13][14]. - It has established a solid customer base, including major global automotive parts suppliers, which contributes to stable revenue growth [27]. 2. Industry Analysis - The needle bearing market is experiencing a favorable growth trend, driven by demand from new energy vehicles and industrial robotics, with a projected market size growth rate of 9.3% in 2024 [41]. - The industry is witnessing a consolidation trend, with the company positioned to benefit from this shift due to its competitive advantages and market positioning [43]. 3. Competitive Advantages - The company has a robust R&D framework, with a high percentage of R&D personnel and significant investment in technology, allowing it to break foreign monopolies in high-end sectors [3][57]. - Its customer resource network is well-established, with deep ties to top-tier clients, enhancing its market competitiveness [3][50]. 4. Financial Performance and Forecast - The company has shown steady revenue growth, with a compound annual growth rate of 13.4% from 2020 to 2024, and is expected to achieve a revenue of 7.25 billion in 2025 [26]. - The gross profit margin is projected to improve significantly, reaching 43.35% by 2027, indicating strong profitability potential [3].